Advocacy intelligence hub — real-time data for patient organizations
HETLIOZ: FDA approved
Treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older
Chirostim: FDA approved
Stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction, stimulation of gastrin secretion to aid in the diagnosis of gastrinoma, and stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography
Secreflo: FDA approved
Use in secretin stimulation testing for stimulation of gastrin secretion to aid in the diagnosis of gastrinoma
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance3
HETLIOZ
Vanda Pharmaceuticals, Inc.
Chirostim
ChiRhoClin, Inc.
Secreflo
ChiRhoClin, Inc.
Secreflo
(Synthetic porcine secretin)Orphan drugChiRhoClin, Inc.
Browse all OBSOLETE: Syndrome associated with Pierre Robin syndrome news →
View all OBSOLETE: Syndrome associated with Pierre Robin syndrome specialists →